Mytide Therapeutics
Manufacturing custom peptides for researchers.
Launch date
Employees
Market cap
-
Enterprise valuation
$28—42m (Dealroom.co estimates Mar 2022.)
Boston Massachusetts (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$200k | Grant | ||
$430k | Grant | ||
N/A | - | ||
* | $7.0m | Series A | |
Total Funding | $7.6m |
Related Content
Recent News about Mytide Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.